Medtronic plc.

123.78-0.9600-0.77%Vol 6.23M1Y Perf 36.12%
Jun 11th, 2021 16:00 DELAYED
BID123.00 ASK125.00
Open124.88 Previous Close124.74
Pre-Market- After-Market123.78
 - -  - -%
Target Price
137.55 
Analyst Rating
Moderate Buy 1.57
Potential %
11.12 
Finscreener Ranking
★+     45.59
Insiders Trans % 3/6/12 mo.
-100/-100/-88 
Value Ranking
★★+     48.32
Insiders Value % 3/6/12 mo.
-100/-100/-92 
Growth Ranking
★★★     54.01
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-92 
Income Ranking
★★★     47.23
Market Cap166.86B 
Earnings Rating
Buy
Price Range Ratio 52W %
80.91 
Earnings Date
27th May 2021

Today's Price Range

123.17124.90

52W Range

87.68132.30

5 Year PE Ratio Range

21.1044.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.06%
1 Month
0.54%
3 Months
4.18%
6 Months
10.14%
1 Year
36.12%
3 Years
42.78%
5 Years
45.15%
10 Years
259.47%

TickerPriceChg.Chg.%
MDT123.78-0.9600-0.77
AAPL127.351.24000.98
GOOG2 513.93-7.6700-0.30
MSFT257.890.65000.25
XOM62.17-0.5800-0.92
WFC45.680.59001.31
JNJ164.96-2.1200-1.27
FB331.26-1.2000-0.36
GE13.690.06000.44
JPM160.29-0.1100-0.07
Financial StrengthValueIndustryS&P 500US Markets
1.90
2.60
0.34
0.51
5.20
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
65.20
12.50
22.10
13.60
11.98
RevenueValueIndustryS&P 500US Markets
30.12B
22.39
-0.39
0.45
DividendsValueIndustryS&P 500US Markets
2.03
2.52
8.03
8.58
Payout ratio107.00
Earnings HistoryEstimateReportedSurprise %
Q04 20211.421.505.63
Q03 20211.151.2912.17
Q02 20210.781.0230.77
Q01 20210.210.62195.24
Q04 20200.590.58-1.69
Q03 20201.381.444.35
Q02 20201.281.312.34
Q01 20201.181.266.78
Earnings Per EndEstimateRevision %Trend
7/2021 QR1.310.00-
10/2021 QR1.35-5.59Negative
4/2022 FY5.68-1.22Negative
4/2023 FY6.32-0.47Negative
Next Report Date-
Estimated EPS Next Report1.42
Estimates Count13
EPS Growth Next 5 Years %8.90
Volume Overview
Volume6.23M
Shares Outstanding1.35B
Trades Count53.03K
Dollar Volume682.28M
Avg. Volume4.68M
Avg. Weekly Volume4.90M
Avg. Monthly Volume4.85M
Avg. Quarterly Volume4.74M

Medtronic plc. (NYSE: MDT) stock closed at 123.78 per share at the end of the most recent trading day (a -0.77% change compared to the prior day closing price) with a volume of 6.25M shares and market capitalization of 166.86B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 90000 people. Medtronic plc. CEO is Geoffrey S. Martha.

The one-year performance of Medtronic plc. stock is 36.12%, while year-to-date (YTD) performance is 5.67%. MDT stock has a five-year performance of 45.15%. Its 52-week range is between 87.68 and 132.3, which gives MDT stock a 52-week price range ratio of 80.91%

Medtronic plc. currently has a PE ratio of 46.60, a price-to-book (PB) ratio of 3.24, a price-to-sale (PS) ratio of 5.54, a price to cashflow ratio of 26.90, a PEG ratio of 2.32, a ROA of 3.74%, a ROC of 4.37% and a ROE of 6.73%. The company’s profit margin is 11.98%, its EBITDA margin is 22.10%, and its revenue ttm is $30.12 Billion , which makes it $22.39 revenue per share.

Of the last four earnings reports from Medtronic plc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.42 for the next earnings report. Medtronic plc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Medtronic plc. is Moderate Buy (1.57), with a target price of $137.55, which is +11.12% compared to the current price. The earnings rating for Medtronic plc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Medtronic plc. has a dividend yield of 2.03% with a dividend per share of $2.52 and a payout ratio of 107.00%.

Medtronic plc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 5.51, ATR14 : 2.06, CCI20 : -65.48, Chaikin Money Flow : -0.24, MACD : -0.62, Money Flow Index : 40.32, ROC : -3.60, RSI : 45.33, STOCH (14,3) : 37.70, STOCH RSI : 0.74, UO : 44.29, Williams %R : -62.30), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Medtronic plc. in the last 12-months were: Bradley E. Lerman (Option Excercise at a value of $2 600 082), Bradley E. Lerman (Sold 44 034 shares of value $4 923 062 ), Carol A. Surface (Sold 15 000 shares of value $1 723 500 ), Geoffrey S. Martha (Option Excercise at a value of $614 925), Geoffrey S. Martha (Sold 11 712 shares of value $1 391 736 ), Karen L. Parkhill (Sold 2 004 shares of value $227 547 ), Omar Ishrak (Sold 763 shares of value $82 709 ), Richard H. Anderson (Buy at a value of $499 952), Robert J. White (Sold 10 930 shares of value $1 261 977 ), Robert Ten Hoedt (Option Excercise at a value of $250 020), Robert Ten Hoedt (Sold 26 315 shares of value $2 850 268 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
15 (65.22 %)
16 (66.67 %)
16 (69.57 %)
Moderate Buy
3 (13.04 %)
3 (12.50 %)
2 (8.70 %)
Hold
5 (21.74 %)
5 (20.83 %)
5 (21.74 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.57
Strong Buy
1.54
Strong Buy
1.52

Medtronic plc.

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

CEO: Geoffrey S. Martha

Telephone: +353 14381700

Address: Lower Hatch Street, Dublin 2, , IE

Number of employees: 90 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

55%45%

Bearish Bullish

56%44%

News

Stocktwits